CONCORD, Mass., Jan. 9, 2025 /PRNewswire/ -- Cristcot, a clinical-stage pharmaceutical company advancing innovative therapies for gastrointestinal diseases, today announced positive topline results ...

Discover comprehensive details about Hydrocortisone Acetate and Pramoxine HCl, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid ...

Review the side-effects of Hydrocortisone Acetate and Pramoxine HCl as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the ...

A next-generation hydrocortisone acetate suppository for rectal ulcerative colitis has shown strong Phase 3 results, achieving rapid symptom relief and remission in many patients. Delivered via the ...

AUSTIN, Texas, May 06, 2026 (GLOBE NEWSWIRE)-- Cristcot, a clinical-stage pharmaceutical company advancing targeted therapies for gastrointestinal diseases, today announced the appointment of Rayna ...

-- Prescription Drug User Fee Act (PDUFA) target date of October 2026 -- -- Submission supported by CESSA Phase 3 trial results demonstrating statistically significant rates of clinical remission in ...

Sepsis occurs in approximately 1.7 million hospitalizations in the U.S. with in more than a third of hospitalizations resulting in death. Patients with septic shock benefit from steroid medications ...

Hydrocortisone is a prescription medication. It comes in many forms, including an oral tablet. Hydrocortisone oral tablet is available as the brand-name drug Cortef and in a generic form. Generic ...

Polymyxin B sulfate 10000Units, neomycin sulfate 3.5mg, hydrocortisone 10mg; per mL; contains sulfites. Colistin sulfate is a polypeptide antibiotic which penetrates into and disrupts the bacterial ...

Hydrocortisone-pramoxine topical cream is available as a brand-named drug and a generic drug. Brand name: Pramosone. Hydrocortisone-pramoxine comes in four forms: topical cream, foam, lotion, and ...

Pivotal Phase 3 Data Met Pre-defined Outcomes - Achieving a Clinical Response by Day 15 and Clinical Remission by Day 29 On Track for NDA Submission in Q1 2025 CONCORD, Mass., Jan. 9, 2025 /PRNewswire ...